3 November 2020

Gynaecologist Annemiek Nap has been appointed professor of Reproductive Medicine at Radboud University and Radboudumc with effect from 1 January 2021. In this capacity, Nap will focus on finding solutions to issues in the field of fertility. In addition, she will work on improving the care for women with endometriosis.


Annemiek Nap (Valburg, 1973) worked at the Rijnstate Hospital in Arnhem from 2009 and focused on the areas of fertility and endometriosis (the presence of endometrium‑like tissue outside of the uterus). There, she established a multidisciplinary centre for diagnostics and treatment of endometriosis.

Annemiek passed her final degree examination in Medicine cum laude in 1999 at Radboud University, obtained her PhD in Maastricht (on the dissertation The pathogenesis of endometriosis: Sampson was right) and remained there to follow training to become a gynaecologist. She is no stranger to the Radboudumc: she was a fellow in Reproductive Medicine at the Radboudumc from 2010 to 2012.

Reproductive Medicine Manual

Through collaborations with various partners, Annemiek Nap has made major contributions to the knowledge in her field. She and her colleagues wrote the Handboek Voortplantingsgeneeskunde (Reproductive Medicine Manual), she is the chair of the Reproductive Medicine pillar of the Dutch Association for Obstetrics and Gynaecology (NVOG), and she was involved in the establishment of the European guideline on the management of women with endometriosis, amongst other accomplishments. She is also a member of the board of the World Endometriosis Society. Through national and international collaborations, she seeks to fill in the gaps in knowledge in the field of gynaecology.

Related news items

T-Guard can reset immune system

1 December 2021

For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.

read more

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

1 December 2021

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

read more

Participating in cancer research among people with intellectual disabilities

30 November 2021

Thanks to the support of the Maarten van der Weijden Foundation research was carried out into the participation of people with intellectual disabilities in (population) screening for cancer.

read more

Dutch-Nordic Alliance for Precision Cancer Medicine launched

26 November 2021

The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.

read more

New anti-inflammatory drugs increase risk of fungal infection

22 November 2021

Investigators at the Department of Internal Medicine / Infectious Diseases and Dermatology demonstrate worldwide side effects of certain so-called biologics using four different research approaches

read more

Survey of patients to address knee pain from removed meniscus

19 November 2021

Patients with persistent knee pain after meniscus removal can participate at three locations in the Netherlands in the AIR2 study by ATRO Medical, a spin-off of the Radboudumc and DSM.

read more